StonvexLoading…
StonvexStonvexStonvexCore line items from ACCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.52B | $1.67B | $1.83B | $1.95B |
Operating Income | $92.30M | $-37.00M | $44.70M | $34.80M |
Net Income | $41.30M | $-101.60M | $-21.80M | $-13.20M |
EPS (Diluted) | $0.44 | $-1.06 | $-0.23 | $-0.14 |
Total Assets | $2.25B | $2.23B | $2.64B | $2.79B |
Total Liabilities | $1.59B | $1.62B | $1.86B | $1.98B |
Cash & Equivalents | $64.40M | $74.10M | $66.40M | $62.20M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $59.90M |
Shares Outstanding | 90.14M | 92.88M | 94.90M | 94.30M |